1. Therapeutic anticoagulation with rivaroxaban or enoxaparin did not improve clinical outcomes and increased bleeding compared with prophylactic anticoagulation.
2. Net clinical benefit composite of death, thrombotic events, and major or clinically relevant non-major bleeding was not significantly different between groups.
Evidence Rating Level: 1 (Excellent)
Study Rundown: COVID-19 is associated with...
1. Among trauma patients aged 10 to 17, the use of low molecular weight heparin as compared with unfractionated heparin was associated with fewer episodes of venous thromboembolism as well as a reduction in mortality.
Evidence Level Rating: 2 (Good)
Low molecular weight heparin (LMWH) and unfractionated heparin (UFH) are the...